Abstract
Rats with partial (36%) 6-hydroxydopamine-induced lesions of the striatal dopamine system or sham-lesioned controls were tested for duration of catalepsy after 1.0, 2.0 and 4.0 mg/kg haloperidol. Thereafter, half of each group was given haloperidol (2.0 mg/kg) chronically for 84 days. The cataleptic responses to the 3 doses were tested again on days 13-15 and 74-76 of the chronic injections. Animals that were lesioned and treated with haloperidol chronically had longer durations of catalepsy at the first two dose-response determinations. At the third dose-response determination, there were no differences among the 4 groups. Additionally, all groups displayed an increase in duration of catalepsy at the second and third dose-response determinations, relative to the first. The increase in haloperidol-induced duration of catalepsy in the lesioned group suggests that lower levels of dopamine in the striatum may potentiate extrapyramidal side-effects.
References
Feb 7, 1977·European Journal of Pharmacology·C Ezrin-Waters, P Seeman
Sep 1, 1978·Neuropharmacology·B CostallR J Naylor
Jul 1, 1976·Neuropharmacology·M E Stanley, S D Glick
Oct 1, 1976·Neuropharmacology·T Honma, H Fukushima
Jul 23, 1975·Psychopharmacologia·B Costall, R J Naylor
Apr 1, 1990·Pharmacology, Biochemistry, and Behavior·S FerréM Casas
Jan 1, 1989·Psychopharmacology·J LappalainenE Syvälahti
Jul 1, 1989·Pharmacology, Biochemistry, and Behavior·S IwataT Fukuda
Jan 1, 1987·Psychopharmacology·O P Yntema, J Korf
Oct 1, 1988·Behavioral Neuroscience·P R SanbergA B Norman
Jan 1, 1986·Psychopharmacology·C J de Graaf, J Korf
Jan 1, 1988·Psychopharmacology·D C Hoffman, R J Beninger
Dec 1, 1971·Experimental Gerontology·E G McGeerV Wickson
Mar 30, 1973·Brain Research·C E Finch
Jan 1, 1980·Psychopharmacology·P R SanbergH C Fibiger
Oct 29, 1982·Science·C X Poulos, R Hinson
Apr 3, 1980·Nature·P R Sanberg
Sep 28, 1981·Life Sciences·A Campbell, R J Baldessarini